How drugs cross the formidable blood brain barrier in order to function is not well understood, specifically with respect to the interplay between hydrophobic and hydrophilic interactions in solution. BBB-crossing drugs must be hydrophilic enough to be delivered to the brain through the blood stream, yet hydrophobic enough to cross into the central nervous systems. Here we propose to investigate the atomic structure of a drug which can cross the BBB with lipids in amphiphilic solutions which mimic the environment presented by the the central nervous system. This will provide atomic scale insights into the mechanisms by which drugs molecules can pass into the brain in order to function.